LUTONIX: payments to doctors
Payments that named LUTONIX as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $797K
- Providers
- 1,987
- Transactions
- 4,656
- Average per transaction
- $171
The per-transaction average — $171 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,987 providers the average total is $401, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| BARD Peripheral Vascular, Inc. | $426,669 | 53.5% |
| Bard Peripheral Vascular, Inc. | $250,217 | 31.4% |
| BD | $102,025 | 12.8% |
| C. R. BARD, Inc. & Subsidiaries | $14,333 | 1.8% |
| C. R. Bard, Inc. & Subsidiaries | $3,780 | 0.5% |
| Davol Inc. | $88 | 0.0% |
| Bard Access Systems, Inc. | $65 | 0.0% |